Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• IceCure Medical Ltd (NASDAQ:ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
• TaskUs, Inc. (NASDAQ:TASK) shares climbed 37.1% to $21.99 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
• Oportun Financial Corporation (NASDAQ:OPRT) gained 36.1% to $5.65 after the company announced upbeat Q3 results.
• GrowGeneration Corp. (NASDAQ:GRWG) shares climbed 29.9% to $4.30 after the company reported better-than-expected Q3 sales.
• SkyWater Technology, Inc. (NASDAQ:SKYT) gained 25.8% to $10.87 after the company reported better-than-expected Q3 EPS and sales results.
• Exela Technologies, Inc. (NASDAQ:XELA) rose 25% to $0.2161.
• Allakos Inc. (NASDAQ:ALLK) jumped 25% to $7.65 following a narrower-than-expected Q3 loss.
• Triumph Group, Inc. (NYSE:TGI) surged 23.7% to $11.77 after the company reported upbeat quarterly sales and raised FY23 earnings guidance.
• Unique Fabricating, Inc. (NYSE:UFAB) surged 23.4% to $0.6480.
• eHealth, Inc. (NASDAQ:EHTH) gained 22.6% to $3.90 following strong Q3 results.
• Rover Group, Inc. (NASDAQ:ROVR) jumped 22.3% to $5.04 after the company posted a narrower quarterly loss and issued strong sales forecast.
• NeoGenomics, Inc. (NASDAQ:NEO) gained 21.5% to $8.63 following better-than-expected Q3 results.
• Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) jumped 19.3% to $3.9950 following Q3 results.
• Avalon GloboCare Corp. (NASDAQ:AVCO) rose 19.2% to $0.6695. Avalon Globocare reported a deal to buy 60% interest in Laboratory Services MSO for $31 million in cash and preferred shares.
• AAON, Inc. (NASDAQ:AAON) gained 19.2% to $78.13 following upbeat Q3 resulst.
• Hims & Hers Health, Inc. (NYSE:HIMS) rose 19% to $5.50 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
• Loyalty Ventures Inc. (NASDAQ:LYLT) jumped 18.6% to $1.7200 following Q3 results.
• Bit Brother Limited (NASDAQ:BTB) gained 18.1% to $0.1520.
• SolarEdge Technologies, Inc. (NASDAQ:SEDG) rose 17.7% to $248.77 after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
• First Advantage Corporation (NASDAQ:FA) gained 17% to $12.14 following Q3 results.
• Ocuphire Pharma, Inc. (NASDAQ:OCUP) shares rose 16.5% to $2.4350. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
• CTI BioPharma Corp. (NASDAQ:CTIC) rose 16.4% to $5.78 after the company reported better-than-expected Q3 EPS and sales results.
• Five9, Inc. (NASDAQ:FIVN) gained 16.4% to $54.71 following Q3 results.
• Veritiv Corporation (NYSE:VRTV) gained 16.1% to $126.27 after the company posted upbeat Q3 results and raised FY22 EPS guidance.
• Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 16% to $40.51 following Q3 results.
• Selina Hospitality PLC (NASDAQ:SLNA) gained 15.8% to $4.4966.
• Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares rose 15% to $2.2083. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
• Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 14% to $3.3313 after the company reported Q3 financial results.
• International Game Technology PLC (NYSE:IGT) jumped 13.8% to $22.72. International Game Technology reported third-quarter FY22 revenue growth of 14% year-on-year to $1.06 billion (at constant currency), beating the consensus of $1.01 billion.
• Lordstown Motors Corp. (NASDAQ:RIDE) rose 12.7% to $2.0840 after the company announced Foxconn will invest up to $170 million in the company.
• uCloudlink Group Inc. (NASDAQ:UCL) rose 11% to $1.0227 after gaining over 4% on Monday.
• SunPower Corporation (NASDAQ:SPWR) gained 10.4% to $18.62 after the company reported better-than-expected Q3 EPS and sales results.
• The Hain Celestial Group, Inc. (NASDAQ:HAIN) rose 10.3% to $20.99 following upbeat quarterly earnings.
• Planet Fitness, Inc. (NYSE:PLNT) gained 9.5% to $67.60 after the company reported better-than-expected Q3 adjusted EPS and sales results.
• LivePerson, Inc. (NASDAQ:LPSN) rose 8.9% to $11.02 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
• Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) gained 7.7% to $17.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 guidance.
• 2U, Inc. (NASDAQ:TWOU) rose 3.6% to $6.58 after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.

Losers

• NanoString Technologies, Inc. (NASDAQ:NSTG) shares dipped 47.5% to $4.84 after the company reported worse-than-expected Q3 results.
• Fast Radius, Inc. (NASDAQ:FSRD) dropped 47% to $0.1533 after the company filed voluntary petitions for relief under Chapter 11.
• Bioventus Inc(NASDAQ:BVS) fell 45.1% to $3.8750 after the company reported downbeat Q3 results and lowered FY22 guidance.
• R1 RCM Inc. (NASDAQ:RCM) dropped 44.2% to $8.23 after the company reported worse-than-expected Q3 EPS and sales results and cut FY22 revenue guidance below estimates.
• Unisys Corporation (NYSE:UIS) fell 41.2% to $5.27 following downbeat quarterly sales.
• NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) dipped 40.5% to $1.2850 after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
• Athersys, Inc. (NASDAQ:ATHX) shares fell 38% to $1.40 after the company reported a proposed public offering.
• Party City Holdco Inc. (NYSE:PRTY) dipped 38% to $0.9499 after the company reported worse-than-expected Q3 results.
• Arrival (NASDAQ:ARVL) dropped 36.7% to $0.3755 after the company announced a Q3 business update.
• Digital Brands Group, Inc. (NASDAQ:DBGI) declined 28% to $4.7650.
• The Pennant Group, Inc. (NASDAQ:PNTG) fell 27.2% to $9.87 following downbeat quarterly earnings.
• Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPA) dropped 26% to $0.9349.
• WM Technology, Inc. (NASDAQ:MAPS) dipped 25.1% to $1.4450 after the company reported worse-than-expected Q3 sales results.
• Clarus Corporation (NASDAQ:CLAR) dropped 24.9% to $8.27 after the company reported worse-than-expected Q3 results and issued FY22 guidance below estimates.
• Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 24.5% to $1.23 following weak quarterly results.
• ATI Physical Therapy, Inc. (NASDAQ:ATIP) declined 24.2% to $0.8495 after the company said there is doubt about its ability to continue as a going concern within 12 months following the issuance date of its financial statements for the period ended Sept. 30
• Tripadvisor, Inc. (NASDAQ:TRIP) shares fell 21.8% to $18.61 after the company reported worse-than-expected Q3 EPS results.
• Versus Systems Inc. (NASDAQ:VS) dropped 20.6% to $0.1801 after the company announced a 1-for-15 reverse stock split to aid compliance with Nasdaq listing requirements.
• Lyft, Inc. (NASDAQ:LYFT) shares fell 20.2% to $11.29 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
• Cognition Therapeutics, Inc. (NASDAQ:CGTX) dipped 19.8% to $1.3699 after the company filed for an offering of up to 5.6 million shares of common stock.
• Kaleyra, Inc. (NYSE:KLR) dropped 19.5% to $0.6676 following weak quarterly sales.
• Akoya Biosciences, Inc. (NASDAQ:AKYA) fell 18.3% to $10.63 as the company posted a wider-than-expected quarterly loss.
• MeridianLink, Inc. (NYSE:MLNK) fell 17.9% to $13.24 after reporting a loss for the tird quarter.
• Ocular Therapeutix, Inc. (NASDAQ:OCUL) dipped 17.8% to $2.9199 following Q3 loss.
• Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) dropped 17.8% to $4.61 after the company reported Q3 financial results.
• Broadmark Realty Capital Inc. (NYSE:BRMK) fell 16.4% to $4.7050 after reporting downbeat quarterly results. The company also named Jeffrey Pyatt as Interim CEO and Jonathan Hermes as Chief Financial Officer.
• MicroStrategy Incorporated (NASDAQ:MSTR) dropped 14.5% to $228.00 in sympathy with the price of Bitcoin and Ethereum.
• Silvergate Capital Corporation (NYSE:SI) declined 14.4% to $43.59. Silvergate announced changes to its executive team.
• Perrigo Company plc (NYSE:PRGO) dropped 14.1% to $33.75 as the company lowered FY22 profit forecast.
• Lumentum Holdings Inc. (NASDAQ:LITE) fell 13.8% to $60.62 after the company issued Q3 EPS and sales guidance below estimates.
• Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 13.8% to $0.2749 after the company reported a loss for its third quarter.
• ChromaDex Corporation (NASDAQ:CDXC) dropped 13.2% to $1.8753.
• Alto Ingredients, Inc. (NASDAQ:ALTO) fell 12.9% to $3.6150 after the company reported Q3 earnings. The company said results were impacted by logistical constraints, increased transportation costs and low commodity margins.
• Take-Two Interactive Software, Inc. (NASDAQ:TTWO) fell 12.2% to $95.13 after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
• SI-BONE, Inc. (NASDAQ:SIBN) dipped 12.1% to $14.73 following Q3 results.
• FibroGen, Inc. (NASDAQ:FGEN) fell 11.8% to $14.24 following weak quarterly results.
• Ramaco Resources, Inc. (NASDAQ:METC) shares fell 11.2% to $11.07 after the company reported worse-than-expected Q3 results.
• Coinbase Global, Inc. (NASDAQ:COIN) dropped 10.2% to $51.17. Crypto-related stocks dropped sharply amid marked, ongoing volatility in the broader crypto space amid reports of a possible bankruptcy of popular cryptocurrency exchange FTX.
• MicroCloud Hologram Inc. (NASDAQ:HOLO) shares fell 8.6% to $2.14 after dropping over 7% on Monday.
• DigitalOcean Holdings, Inc. (NASDAQ:DOCN) fell 6.6% to $27.46 after the company issued a weak forecast for the fourth quarter.